Date: Saturday, June 2, 2018
Session Time: 5:30pm-7:30pm
Presentation Time: 5:30pm-7:30pm
Location: Hall 4EF
Background: We aim to analyze patients undergoing re-transplantation for HAT in the US.
Methods:Between 1995 and 2015, 623 patients were re-transplanted for HAT identified in the UNOS dataset.
Results: The mean age in the HAT group was 51.25+10.4 years, mean BMI was 26.72 kg/m2, and mean MELD score was 19.62+9.09. HAT recipients were more likely to be male, older, with higher rates of pre-transplant portal vein thrombosis (7.4 vs. 5.4%, p=0.04), lower incidence of hepatitis C (29.5% vs. 35.8%, p=0.002), shorter length of hospitalization (23 vs. 26 days, p=0.02), shorter waiting time for transplant (61 vs. 111 days, p=0.001), and had lower 90 day mortality (16% vs. 20%, p=0.02). Patients re-transplanted for HAT had 13% decrease risk of graft loss and 13% increased long term survival. After case-control matched analysis graft and patient survival was significantly better in the HAT group. Late re-transplantation for HAT was associated with a decreased graft and patient survival compared to those re-re-transplanted early (within 30days).
Conclusions: Selected patients undergoing re-transplantation for HAT have better outcomes compared to those re-transplanted for other indications. Early re-transplantation is associated with better outcomes and should be considered in those with HAT.
CITATION INFORMATION: Garcia C., Mei X., Marti F., Shah M., Berger J., Daily M., Gupta M., Gedaly R. Re-Transplantation for Hepatic Artery Thrombosis: A National Perspective Am J Transplant. 2017;17 (suppl 3).
To cite this abstract in AMA style:Garcia C, Mei X, Marti F, Shah M, Berger J, Daily M, Gupta M, Gedaly R. Re-Transplantation for Hepatic Artery Thrombosis: A National Perspective [abstract]. https://atcmeetingabstracts.com/abstract/re-transplantation-for-hepatic-artery-thrombosis-a-national-perspective/. Accessed June 6, 2020.
« Back to 2018 American Transplant Congress